All posts tagged: THC

CED Foundation Archive

This week, CED Foundation added 77 more #cannabis studies, & 50 about #flavonoids. Read & search for free, and please consider uploading so that others may enjoy the materials you have! This week’s folder: http://bit.ly/2KYfOCF For the whole archive: http://tinyurl.com/MMJarchive

Benjamin Caplan, MDCED Foundation Archive
read more

Dronabinol: antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns

Study provides rigorous data to support clinical evaluation of THC as a low-toxic therapy option in acute leukemia patients. In related work, full-spectrum, natural derivatives of cannabis may work more effectively than their pharmaceutical counterparts.

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2KVVXnD     inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDDronabinol: antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns
read more

How to prevent inappropriate teen use?

Especially in Colorado and Washington, people are taking note of teens’ use and access to potent marijuana, and many are concerned that there are not enough measures in place to prevent this. Newly legalized states should look into this before it becomes a national issue. https://wapo.st/2Fgmto9

Benjamin Caplan, MDHow to prevent inappropriate teen use?
read more

Evidence for Therapeutic Benefits of Cannabidiol, Including Treatment of Ischemic Strokes

Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke

Cannabidiol (CBD) has a unique therapeutic profile as it has a cannabinoid receptor-independent mechanism, limited side-effects, and patients do not seem to develop an insurmountable tolerance. Research currently focussed on the therapeutic benefits of CBD has demonstrated long-lasting neuroprotective properties against global and focal ischemic injury, such as ischemic stroke. This piece points to CBD as a major component of cannabis-based medicine as a non-psychoactive component. Further research is needed to evaluate the full clinical capabilities of CBD, including its neuroprotective effect.

View this review (yellow link) or download:

The US patent on Cannabinoids as Antioxidants and Neuroprotectants, from 1999: https://patents.google.com/patent/US6630507B1/en

This paper is also stored here:    http://bit.ly/2L0PBn3     inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDEvidence for Therapeutic Benefits of Cannabidiol, Including Treatment of Ischemic Strokes
read more

Researchers Look to CBD and THC for the Treatment of Chronic Pain

Efficacy and safety of cannabidiol followed by an open-label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomized, placebo-controlled study

Current researchers have proposed a study protocol that would expose any possible benefits of cannabidiol (CBD) and tetrahydrocannabinol (THC) for the treatment of chronic pain in patients suffering from rheumatoid arthritis (RA) and ankylosing spondylitis (AS). This new study hopes to identify how medical cannabis affects pain and cognitive function in RA and AS and provide evidence that cannabis-based pain medication is an alternative to opioids with fewer risks.

This paper is also stored here:    http://bit.ly/2Fb08s5     inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDResearchers Look to CBD and THC for the Treatment of Chronic Pain
read more

The Education of Dispensary Staff is Varied and Lacks Regulation

Training and Practices of Cannabis Dispensary Staff

How much medical training does your local budtender possess? An online survey sent to medical marijuana dispensary staff reported only 55% of staffers had any formal training for their position, with 20% reporting some background in medical/scientific training. The analysis reported that many among the dispensary staff are recommending cannabis choices that are consistent with current evidence, but some are recommending strains that are either ineffective or exacerbate a patient’s condition. The findings of this study stress the importance of consistent and well-regulated training of dispensary staff.

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2FfJNSC     inside the CED Foundation Archive

To explore related information, click the keywords below:

Benjamin Caplan, MDThe Education of Dispensary Staff is Varied and Lacks Regulation
read more

High-potency cannabis and incident psychosis: correcting the causal assumption

Scientists offer a strong counter-position to the belief that cannabis causes psychosis, pointing out the difference between correlation and causation. They argue that smoke exposure from any source (including cigarettes) could explain the reported link between cannabis and psychosis. 

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2WHtDr8     inside the CED Foundation Archive

To explore related information, click keywords below:

Benjamin Caplan, MDHigh-potency cannabis and incident psychosis: correcting the causal assumption
read more

Treating insomnia with cannabis

Many people use cannabis to treat insomnia, as THC has proven effects. What about CBD? There are no clear, incontrovertible studies, and effects differ by the user, but there are promising results. More noticeably, certain terpenes have been shown to be quite effective, for example, Myrcene. http://bit.ly/2F9PXUp

Benjamin Caplan, MDTreating insomnia with cannabis
read more

Cannabinoids in Attention- Deficit/Hyperactivity Disorder: A randomized-controlled trial

In a placebo-controlled study of a cannabis oral spray in patients with ADHD, there was no significant improvement in cognitive performance, but there was a significant improvement in hyperactivity and impulsivity.

View this review (yellow link) or download:

This paper is also stored here:     http://bit.ly/31ykZiz    inside the CED Foundation Archive

To explore related information, click keywords below:

Benjamin Caplan, MDCannabinoids in Attention- Deficit/Hyperactivity Disorder: A randomized-controlled trial
read more

Cannabidiol in Anxiety and Sleep: A Large Case Series

In a study of 72 psychiatric patients given CBD in capsule form, researchers found that cannabidiol successfully decreased anxiety and improved sleep over the course of three months. 

View this review (yellow link) or download:

This paper is also stored here:    http://bit.ly/2WDo4yV     inside the CED Foundation Archive

To explore related information, click keywords:

Benjamin Caplan, MDCannabidiol in Anxiety and Sleep: A Large Case Series
read more